Skip to content

ENDOCAUCH

Active
Private limited companyfounded 2021active for 5 yearsChaussée de Wavre 116, 1330 Rixensart, BelgiumKBO/BCE: BE 0764.475.410
Summary

ENDOCAUCH has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €13,000 and a net result of €36,181. Equity has been shrinking by about 22% per year since 2021. Its solvency ranks better than 20% of 20,720 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 01-03-2021 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment units
2.313.925.496 1150 Sint-Pieters-Woluwe, since 01-03-2021
2.313.925.694 1330 Rixensart, since 01-03-2021
Financial year end
31 December
Peppol
Reachable since 26-10-2025

Board and ownership

Board
  • Caucheteur BernardDirector

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€60,270
▲ 88.0%
Turnover
≈ €140,000
estimated
Profit
€36,181
▲ 119%
Equity
€13,000
=
Total assets
€61,517
▼ 49.3%
Score breakdownlowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 0.93, cash €38,612, halvedSize: total assets €61,517Figures for financial year 2025 (filed on 09-04-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 43% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 46+10
equity 21.1% of total assets
Liquidity 57+6
short-term debt 78.5% · cash 62.8%
Profitability 100+14
return on assets 58.8%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,168 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025lowest value 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026highest value 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026 11-2026: < 0.1%● unchanged vs 10-2026
Credit of up to €1,000 on 30-day terms is acceptable
Liquidity is insufficient, with a current ratio of 0.93 (0.91 in 2024), below 1. Short-term debt is 78.5% and cash 62.8% of total assets. 78.9% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 21% of them on solvency, 33% on liquidity, 80% on profitability and 37% on growth.

The bankruptcy probability was computed on 03-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 0.93, cash €38,612, halved
NBB · annual accounts
lowers risk · Size: total assets €61,517
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 09-04-2026)
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 20% of 20720 sector peers (2025).
NBB · sector comparison
Position among 20720 sector peers
Solvency
better than 20%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 09-04-2026, 113 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
113 days early
2024
76 days early
2023
118 days early
2022
81 days early
2021
31 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 84 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 11 May (4 of the last 5 accounts filed within 36 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
04-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Less equity than 86% of companies in human healthsector median €124,634 · 20,722 companies €13,000 View
  • Positive: Always filed on timeaccounts within the deadline every year 5 years View
  • Positive: 5 profitable years in a rowprofit 2025: €36,181 5 years View

Recent changes

  1. · Gazette deed Incorporation
All 9 events

Comparable companies

These companies have the same main activity as ENDOCAUCH: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €54,800 and €71,500, founded between 2020 and 2021.

CompanyTotal assetsGross margin
ENDOCAUCH Rixensart€61,517€60,270
Société Médicale Christophe Bastin Juprelle€57,027€61,265
Dr F. GESTER, pneumologue Trooz€57,099€56,946
GD EXPERTISE MEDICAL Brussel€71,481€59,789
Dokter Zeno Van Duppen Mechelen€66,774€55,742
Dokter Katja Van Oostveldt, Huisarts/Sportarts Gent€58,545€67,970
Dr Mayele M'Peko Osawa Liège€54,821€54,563
Full comparison

Key facts about ENDOCAUCH

What is the company number of ENDOCAUCH?
The company number of ENDOCAUCH is 0764.475.410. The VAT number is the same number with BE in front: BE 0764.475.410.
Where is ENDOCAUCH based?
The registered office is at Chaussée de Wavre 116, 1330 Rixensart.Company details
What does ENDOCAUCH do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of ENDOCAUCH?
The legal form of ENDOCAUCH is Private limited company (BV).
When was ENDOCAUCH founded?
ENDOCAUCH was founded on 01-03-2021.
Is ENDOCAUCH still active?
Yes, ENDOCAUCH is an active enterprise in the KBO register.
What is the turnover of ENDOCAUCH?
The turnover in financial year 2025 is ≈ €140,000. This figure is estimated from the gross margin of €60,270 and 32 comparable companies (NACE 862). It probably lies between €100,000 and €170,000.Financials
Is ENDOCAUCH profitable?
In financial year 2025, ENDOCAUCH made a profit of €36,181.
Where can I find the annual accounts of ENDOCAUCH?
ENDOCAUCH filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ENDOCAUCH due?
ENDOCAUCH must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.